Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kjell Rensfeldt"'
Autor:
Aditya K. Gupta, Amir Tavakkol, Steven Kempers, David M. Pariser, Kjell Rensfeldt, Maria S. Surprenant
Publikováno v:
Journal of the American Academy of Dermatology. 85:95-104
Onychomycosis is a recalcitrant fungal nail infection. Topical antifungal agents may be preferred over systemic agents due to lack of systemic adverse effects.To investigate the efficacy and safety of topical terbinafine 10% solution (MOB-015) for th
Autor:
Louise Strömbeck, Jan Faergemann, Erja Chryssanthou, Lena Klingspor, Kjell Rensfeldt, Kjell Hultenby
Publikováno v:
Mycoses. 57:630-638
K101 Nail Solution (trademarks Emtrix(®), Nalox(™), Naloc(™)) is a combination of propylene glycol, urea and lactic acid in a topical formulation for the treatment of nails affected by onychomycosis. The aim of this study was to investigate the
Publikováno v:
Mycoses. 55:393-403
Alternative treatments for seborrhoeic dermatitis are needed because of the increasing risk of anti-fungal resistance to existing therapies. To investigate the efficacy, safety and tolerability of topical scalp treatment with K301 solution. Two multi
Publikováno v:
Journal of Cosmetics, Dermatological Sciences and Applications. :59-63
Onychomycosis is a fungal infection of the nails of the fingers and toes and is difficult to cure. A previous 24-week, placebo-controlled study demonstrated that a solution containing propylene glycol, urea and lactic acid (K101) was well-tolerated a
Autor:
Jonas Hugosson, Kjell Rensfeldt, Knud Venborg Pedersen, Göran Ahlgren, Gunnar Aus, Rajne Söderberg
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 31:541-544
The optimal number of core biopsies of the prostate that are needed for the detection of prostate cancer is unknown. A retrospective review of protocols and charts concerning 1149 transrectal ultrasound examinations with biopsy performed in 1013 pati
Publikováno v:
Mycoses. 55(5)
Alternative treatments for seborrhoeic dermatitis are needed because of the increasing risk of anti-fungal resistance to existing therapies. To investigate the efficacy, safety and tolerability of topical scalp treatment with K301 solution. Two multi